SILVIA GUIL LUNAJUAN RAFAEL DE LA HABA RODRIGUEZMª AUXILIADORA GÓMEZ ESPAÑAALEJANDRA PERA PERA2026-01-292026-01-29202310.1016/j.biopha.2023.1155922-s2.0-85172199223https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36937PharmacologyClinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapyresearch article